![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/00 | (2006.01) |
A61P 21/00 | (2006.01) | ||
C07K 16/22 | (2006.01) |
(11) | Number of the document | 3368069 |
(13) | Kind of document | T |
(96) | European patent application number | 17732001.7 |
Date of filing the European patent application | 2017-06-13 | |
(97) | Date of publication of the European application | 2018-09-05 |
(45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
(46) | Date of publication of the claims translation | 2020-12-10 |
(86) | Number | PCT/US2017/037332 |
Date | 2017-06-13 |
(87) | Number | WO 2017/218592 |
Date | 2017-12-21 |
(30) | Number | Date | Country code |
201662349596 P | 2016-06-13 | US | |
201762470157 P | 2017-03-10 | US | |
201762486934 P | 2017-04-18 | US | |
201762511702 P | 2017-05-26 | US | |
201762512254 P | 2017-05-30 | US |
(72) |
LONG, Kimberly, US
DONOVAN, Adriana, US
CHYUNG, Yung, US
STRAUB, Michelle, US
|
(73) |
Scholar Rock, Inc.,
301 Binney Street, 3rd Floor, Cambridge, MA 02142,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Miostatino inhibitorių naudojimas, ir kombinuotas gydymas |
USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES |
Payment date | Validity (years) | Amount | |
2025-05-23 | 9 | 208.00 EUR |
2026-06-13 |